Noritaka Ishii
Overview
Explore the profile of Noritaka Ishii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoneyama F, Okamoto T, Tamura Y, Ishii N, Togashi K, Soma O, et al.
Int Urol Nephrol
. 2024 Jan;
56(6):1803-1810.
PMID: 38216828
Purpose: We assessed the association between oral frailty risk and LUTS among middle-aged and older adults in a community-dwelling population. Methods: This cross-sectional study was conducted among 586 subjects aged ...
2.
Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, et al.
Int J Urol
. 2023 Mar;
30(7):572-578.
PMID: 36941076
Objectives: To investigate the impact of global aging on the trends in the age of hospitalized patients with a urological cancer diagnosis. Methods: We retrospectively evaluated a cumulative total of...
3.
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Fukuda M, Shinozaki T, et al.
Sci Rep
. 2023 Mar;
13(1):3436.
PMID: 36859718
We compared the impact of treatment strategies on postoperative complications and prognosis between robot-assisted radical prostatectomy (RARP) plus extended pelvic lymph-node dissection (ePLND) and RARP plus neoadjuvant chemohormonal therapy (NCHT)...
4.
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, et al.
Prostate
. 2022 Oct;
83(2):198-203.
PMID: 36314250
Background: We aimed to evaluate the effects of apalutamide dose reduction on skin-related adverse events (AEs) and castration-resistant prostate cancer (CRPC)-free survival in patients with advanced prostate cancer (PC). Methods:...
5.
Ishii N, Hatakeyama S, Yoneyama T, Tanaka R, Narita T, Fujita N, et al.
Urol Oncol
. 2022 Aug;
40(10):451.e1-451.e8.
PMID: 36008254
Objectives: The effect of concomitant steroid use on the antibody response to a SARS-CoV-2 vaccine in patients with prostate cancer (PC) remains unknown. We aimed to evaluate the rates of...